Serotonin and hypothalamic control of hunger: A review

Revista da Associacao Medica Brasileira

Volumn 57, Issue 1, 2011, Pages 74-77

  De Matos Feijó, Fernanda ^a   Bertoluci, Marcello Casaccia ^a   Reis, Cíntia ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Appetite regulation; Hypothalamus; Satiety response; Serotonin; Serotonin 5 HT2C receptor

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 2 AGONIST; SEROTONIN AGONIST;

ANIMAL; DRUG EFFECT; EATING; HUMAN; HUNGER; HYPOTHALAMUS; METABOLISM; OBESITY; PHYSIOLOGY; REVIEW; SATIETY;

ANIMALS; EATING; HUMANS; HUNGER; HYPOTHALAMUS; NEUROTRANSMITTER AGENTS; OBESITY; SATIATION; SEROTONIN; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN 5-HT2 RECEPTOR AGONISTS; SEROTONIN RECEPTOR AGONISTS;

EID: 79952676699     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302011000100020     Document Type: Review

References (36)

1. Naves A, Paschoal V. Regulação Funcional da Obesidade. Com Scientiae Saúde 2007; 6(1):189-199.
2. Lam DD, Heisler LK. Serotonin and EnergyBalance: Molecular Mechanisms and Implications for Type 2 Diabetes. Expert Reviews in Molecular Medicine 2007; 9(5):1-24.
3. Lam DD, Przydzial MJ, Ridley SH, Yeo GSH, Roshford JJ, O'Rahilly S, et al. Serotonin 5-HT2C Receptor Agonist Promotes Hypophagia via Downstream Activation of Melanocortin 4 Receptors. Endocrinology 2008; 149(3):1323-1328.
4. Blundell JE. Serotonin and the Biology of Feeding. Am J Clin Nutr 1992; 55(1 Suppl):155S-9S.
5. Ward SJ, Lefever TW, Jackson C, Tallarida RJ, Walker EA. Effects of a Cannabinoid 1 Receptor Antagonist and Serotonin 2C Receptor Agonist Alone and in Combination on Motivation for Palatable Food: Dose-Addition Analysis Study in Mice. The Journal of Pharmacology and Experimental Therapeutics 2008; 325:567-576.
6. Ferreira L, Gomes E. Estudo Sobre a Eficácia do Uso de Inibidores da Recaptação de Norepinefrina e Serotonina no Tratamento da Obesidade. Revista Saúde e Pesquisa 2009; 2(3):363-369.
7. Rossi L, Tirapegui J. Implicações do Sistema Serotoninérgico no Exercício Físico. Arq Bras Endocrinol Metab 2004; 48(2):227-233.
8. Ballone GJ-Serotonina- in. PsiqWeb, Internet, disponível em www.psiqweb.med.br, revisto em 2005.
9. Ribeiro EB. Studying the Central Control of Food Intake and Obesity in Rats. Rev Nutr 2009; 22(1):163-171.
10. Bell C, Abrams J, Nutt D. Tryptophan Depletion and its Implications for Psychiatry. Br J Psyc 2001; 178:399-405.
11. Petrisic MS, Augood SJ, Bicknell RJ. Monoamine transporter gene expression in the central nervous system in diabetes mellitus. Journal of Neurochemistry 1997; 68:2435-441.
12. Olivier B, Oorschot R V. 5-HT1B Receptors and Aggression: A Review. Eur J Pharmacol 2005; 526(1-3):207-17.
13. Cambraia RPB. Aspectos Psicobiológicos do Comportamento Alimentar. Rev Nutr 2004; 17(2):217-225.
14. Hermsdorff HHM, Vieira MAQM, Monteiro JBR. Leptina e sua Influência na Patofisiologia de Distúrbios Alimentares. Rev Nutr 2006; 19(3):369-379.
15. Yakabi K, Kurosawa S, Tamai M Yuzurihara M, Nahata M, Ohno S, et al. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction. Regu-Regulatory Peptides 2010; 161:97-105,
16. Luras A. Estudo de Fatores Centrais e Periféricos Relacionados ao Controle da Ingestão Alimentar em Modelos Experimentais. Ensaios e Ciências: C. Biológicas, Agrárias e da Saúde 2009; 13(1):19-27.
17. Garfield AS, Heisler LK. Pharmacological Targeting of the Se-Serotonergic System for the Treatment of Obesity. J Physiol 2009; 587(1):49-60.
18. Simpson KA, Martin NM, Bloom SR. Hypothalamic Regulation of Food Intake and Clinical Therapeutic Applications. Arq Bras Endocrinol Metab 2009; 53(2):120-128.
19. Garfield AS and Heisler LK. Pharmacological targeting of the serotonergic system for the treatment of obesity. J Physiol 2009; 587(1):49-60.
20. Mancini MD, Halpern A. Aspectos Fisiológicos do Balanço Energético. Arq Bras Endocrinol Metab 2002; 46(3):230-248.
21. Bickerdike MJ. 5-HT2C Receptor Agonists as Potential Drugs for the Treatment of Obesity. Current Topics in Medicinal Chemistry 2003; 3:885-897.
22. Miller KJ. Serotonin 5-HT2C Receptor Agonists: Potential for the Treatment of Obesity. Mol Interv 2005; 5(5):282-91.
23. Heisler LK, Jobst EE, Sutton GM, Zhou L, Borok E, Thornton-Jones Z, et al. Serotonin Reciprocally Regulates Melanocortin Neurons to Modulate Food Intake. Neuron 2006; 51(2):239-49.
24. Halford JC, Harrold JA, Boyland EJ, Lawton CL, Blundell JE. Seroto-Serotonergic Drugs: Effects on Appetite Expression and Use for the Treatment of Obesity. Drugs 2007; 67(1):27-55.
25. Heisler LK, Pronchuk N, Nonogaki K, Zhou L, Raber J, Tung L, et al. Serotonin Activates the Hypothalamic-Pituitary-Adrenal Axis via Serotonin 2C Receptor Stimulation. The Journal of Neuroscience 2007; 27(26):6956-6964.
26. Canal CE, Mahautmr KC, Cao C, Bush ES and Airey DC. RNA editing of the serotonin 2C receptor and expression of Gαq protein: genetic mouse models do not support a role for regulation or compensation. J Neurochem 2009; 108(5):1136-1142.
27. Tarazi FI, Moran-Gates T, Wong EHF, Henry B, Shahid M. Asenapine induces differential regional effects on serotonin receptor subtypes. J Psychopharmacol 2010; 24(3):341-348.
28. Baez M, Kursar JD, Helton LA, Wainscott DB, Nelson DLG. Molecular biology of serotonin receptors. Obes Res 1995; 3(Suppl.):4415-75.
29. Smith BK, York DA, Bray GA. Activation of hypothalamic serotonin receptors reduced intake of dietary fat and protein but not carbohydrate. Am J Physiol 1999; 277:802-11.
30. Serpa NA, Saheb GCB, Arantes BS, Pedralli JJ, Silva RBS, Buriti NA. Fatores Ambientais, Comportamentais e Neuroendocrinológicos Envolvidos na Gênese da Epidemia da Obesidade. Arq Bras de Ciências da Saúde 2007; 33(1):44-53.
31. Qiu J, Xue C, Bosch MA, Murphy JG, Fan W, Rønnekleiv OK, Kelly MJ. Serotonin 5-Hydroxytryptamine2C Receptor Signaling in Hypo-Hypothalamic Proopiomelanocortin Neurons: Role in Energy Homeostasis in Females. Mol Pharmacol 2007; 72:885-896.
32. Xu Y, Jones EJ, Kohno D, Williams KW, Lee CE, Choi MJ, et al. 5-HT2CRs Expressed by Pro-Opiomelanocortin Neurons Regulate Energy Homeostasis. Neuron 2008; 26; 60(4-2):582-589.
33. Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, et al. Activation of Central Melanocortin Pathways by Fenfluramine. Science 2002; 297(5581):609-611.
34. Marston OJ, Heisler LK. Targeting the Serotonin 2C Receptor for the Treatment of Obesity and Type 2 Diabetes. Hot Topics Neuropsychopharmacology 2009; 34:252-253.
35. Wade JM, Juneja P, MacKay AW, Graham J, Havel PJ, Tecott LH, Goulding EH. Synergistic Impairment of Glucose Homeostasis in ob/ob Mice Lacking Functional Serotonin 2C Receptors. Endocrinolog 2008; 149(3):955-961.
36. Bechtholt AJ, Smith K, Gaughan S, Lucki I. Sucrose Intake and Fasting Glucose Levels in 5-HT1A and 5-HT1B Receptor Mutant Mice. Physiol Behav 2008; 18, 93(4-5):659-665.